Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

Fig. 2

Trial characteristics of phase II-III clinical trials of metastatic sarcoma presented on ClinicalTrials.gov over time. The percentage of trials each year is shown. The number of target therapies has increased since 2003 and reached its peak in 2008. Between 2003 and 2014, the number of immunotherapy trials and trials initiated in Asia was small, while these proportions increased by 2014

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us